MedPath

Population based cross sectional study for COVID 19 prophylaxis withPolyherbal Siddha formulation Kabasura Kudineer / Nilavembu kudineer in containment zones and noncontainment zones during 2020 pandemic in Tamil Nadu, South India

Not Applicable
Suspended
Registration Number
CTRI/2020/06/025761
Lead Sponsor
ational Institute of Siddha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Suspended
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

a) Laboratory confirmed COVID-19 with or without symptoms

b) Those who are to be excluded in the study, as evaluated by the investigators.

c) Persons intaking Kabasura kudineer / Nilavembu kudineer procured from non GMP

certified pharma companies.

7

d) Persons with poor drug compliance

Exclusion Criteria

a) Laboratory confirmed COVID-19 with or without symptoms

b) Those who are to be excluded in the study, as evaluated by the investigators.

c) Persons intaking Kabasura kudineer / avembu kudineer procured from non GMP

certified pharma companies.

7

d) Persons with poor drug compliance

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
COVID-19 Test Positivity / Negativity upto 31 days follow up.Timepoint: COVID-19 Test Positivity / Negativity upto 31 days follow up.
Secondary Outcome Measures
NameTimeMethod
General and specific health status as described above. <br/ ><br>Immune Status and Function as assessed by ISQTimepoint: 3 months
© Copyright 2025. All Rights Reserved by MedPath